SCHEMBL18539558

SCHEMBL18539558

COC(=O)c1cc(N2C[C@@H](C)O[C@@H](C)C2)nc2c1CCOCC2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.48
AURKA O14965 1/20 0.40
ALDH1A1 P00352 5/20 0.38
WNT3A P56704 1/20 0.37
TNKS2 Q9H2K2 1/20 0.37
AKT1 P31749 2/20 0.36
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
APAF1 O14727 1/20 0.36
NPC1 O15118 1/20 0.36
TDP2 O95551 1/20 0.36
NSD2 O96028 1/20 0.36
PLA2G1B P04054 1/20 0.36
HSP90AA1 P07900 1/20 0.36
PLCG1 P19174 1/20 0.36
RAB9A P51151 1/20 0.36
GALK1 P51570 1/20 0.36
BLM P54132 1/20 0.36
PDIA6 Q15084 1/20 0.36
HKDC1 Q2TB90 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL18528205 0.99 KDM4E (0.47) KDM4EAURKAALDH1A1WNT3ATNKS2
SCHEMBL18528169 0.88 ALDH1A1 (0.46) KDM4EALDH1A1AKT1MEN1KMT2A
SCHEMBL18528154 0.87 KDM4E (0.40) KDM4EALDH1A1KMT2AGAAHPGD
SCHEMBL20365653 0.84 ALDH1A1 (0.43) KDM4EALDH1A1WNT3ATNKS2AKT1
SCHEMBL18539535 0.83 ALDH1A1 (0.41) KDM4EALDH1A1WNT3ATNKS2AKT1
SCHEMBL18539533 0.83 ALDH1A1 (0.39) KDM4EALDH1A1WNT3ATNKS2AKT1
SCHEMBL18539527 0.82 TYK2 (0.40) ALDH1A1WNT3ATNKS2AKT1MEN1
SCHEMBL18548388 0.81 KIF18A (0.35) KDM4EAURKAALDH1A1KMT2ARAB9A
SCHEMBL18539529 0.79 AKT1 (0.42) KDM4EALDH1A1WNT3ATNKS2AKT1
SCHEMBL20365665 0.79 AKT1 (0.42) KDM4EALDH1A1WNT3ATNKS2AKT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9670219-B2 Tetrahydrooxepinopyridine compound ASTELLAS PHARMA INC. (JP) 2017-06-06 US disclosed
US-9670219-B2 Tetrahydrooxepinopyridine compound ASTELLAS PHARMA INC. (JP) 2017-06-06 US disclosed
US-20170050973-A1 TETRAHYDROOXEPINOPYRIDINE COMPOUND ASTELLAS PHARMA INC. (JP) 2017-02-23 US disclosed
US-20170050973-A1 TETRAHYDROOXEPINOPYRIDINE COMPOUND ASTELLAS PHARMA INC. (JP) 2017-02-23 US disclosed
WO-2017030171-A1 TETRAHYDROOXEPINOPYRIDINE COMPOUND アステラス製薬株式会社 2017-02-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170050973-A1 TETRAHYDROOXEPINOPYRIDINE COMPOUND CHRNA7, CHRNA5, P2RX7 KDM4E 2924/4885AURKA 3801/4885ALDH1A1 3958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.